Mersana Therapeutics
MRSN
MRSN
128 hedge funds and large institutions have $144M invested in Mersana Therapeutics in 2023 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 35 increasing their positions, 43 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
19% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 43
42% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 45
61% less capital invested
Capital invested by funds: $370M → $144M (-$226M)
Holders
128
Holding in Top 10
1
Calls
$1.57M
Puts
$76K
Top Buyers
| 1 | +$24.6M | |
| 2 | +$14.4M | |
| 3 | +$5.08M | |
| 4 |
AAA
Affinity Asset Advisors
New York
|
+$3.62M |
| 5 |
PCM
Philosophy Capital Management
Alamo,
California
|
+$2.98M |
Top Sellers
| 1 | -$23.7M | |
| 2 | -$21M | |
| 3 | -$12.5M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$9.97M |
| 5 |
DM
Deerfield Management
New York
|
-$9.49M |